DiRx
-
Competitor: We Are an Established Option Vis-a-Vis Cuban’s Pharmacy Startup
A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed. Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans.
-
‘It’s creating change’: How some startups are circumventing payers
Many startups are giving patients options to receive care that cuts out insurers. This includes online pharmacies, direct primary care platforms and lending companies. These startups are creating change among payers, some experts say.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.